Industry Research Reports
Home > Reports > Pharma & Healthcare > Global C1 Esterase Inhibitor Market Insights, Forecast to 2030
Global C1 Esterase Inhibitor Market Insights, Forecast to 2030
Industry: Pharma & Healthcare
Published Date: 2024-04-25
Pages: 79 Pages
Report ld: 3054011
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
C1 Esterase Inhibitor Market Size(US$)
CAGR 2024-2030
6.1%
Market Size,2030
USD 194
Million
Market Snapshot
Market Size in 2024 (Value)
US$ 136 million
Market Forecast in 2030(Value)
US$ 194 million
CAGR
6.1%
Years Considered
2019-2030
Base Year
2024
Forecast Period
2024-2030
Source: Secondary research, interviews with experts, and QYResearch analysis
C1 esterase inhibitor (C1-INH) is a protein found in the fluid part of your blood.
The global C1 Esterase Inhibitor market is projected to grow from US$ 136 million in 2024 to US$ 194 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.1% during the forecast period.
The C1 esterase inhibitor market has experienced substantial growth in recent years. C1 esterase inhibitor is a therapeutic product used for the treatment of hereditary angioedema (HAE), a rare genetic disorder characterized by recurrent episodes of swelling in various body parts, including the face, extremities, and gastrointestinal tract.The market growth can be attributed to several factors. Firstly, increased awareness and improved diagnostic capabilities have led to a better identification of HAE cases, thereby driving the demand for C1 esterase inhibitor therapy. Secondly, advancements in biotechnology and recombinant DNA technology have paved the way for the development of novel and more efficient C1 esterase inhibitor products, offering improved treatment options for patients.
Report Covers:
This report presents an overview of global market for C1 Esterase Inhibitor, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of C1 Esterase Inhibitor, also provides the sales of main regions and countries. Highlights of the upcoming market potential for C1 Esterase Inhibitor, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the C1 Esterase Inhibitor sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global C1 Esterase Inhibitor market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for C1 Esterase Inhibitor sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including CSL Behring, Takeda and Pharming Intellectual, etc.
MARKET SEGMENTATION
By Company
- CSL Behring
- Takeda
- Pharming Intellectual
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Human
- Recombinant
Segment by Application
- Hospital
- Pharmacy
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of C1 Esterase Inhibitor in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of C1 Esterase Inhibitor manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, C1 Esterase Inhibitor sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 C1 Esterase Inhibitor Product Introduction
1.2 Market by Type
1.2.1 Global C1 Esterase Inhibitor Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Human
1.2.3 Recombinant
1.3 Market by Application
1.3.1 Global C1 Esterase Inhibitor Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global C1 Esterase Inhibitor Sales Estimates and Forecasts 2019-2030
2.2 Global C1 Esterase Inhibitor Revenue by Region
2.2.1 Global C1 Esterase Inhibitor Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global C1 Esterase Inhibitor Revenue by Region (2019-2024)
2.2.3 Global C1 Esterase Inhibitor Revenue by Region (2025-2030)
2.2.4 Global C1 Esterase Inhibitor Revenue Market Share by Region (2019-2030)
2.3 Global C1 Esterase Inhibitor Sales Estimates and Forecasts 2019-2030
2.4 Global C1 Esterase Inhibitor Sales by Region
2.4.1 Global C1 Esterase Inhibitor Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global C1 Esterase Inhibitor Sales by Region (2019-2024)
2.4.3 Global C1 Esterase Inhibitor Sales by Region (2025-2030)
2.4.4 Global C1 Esterase Inhibitor Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global C1 Esterase Inhibitor Sales by Manufacturers
3.1.1 Global C1 Esterase Inhibitor Sales by Manufacturers (2019-2024)
3.1.2 Global C1 Esterase Inhibitor Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of C1 Esterase Inhibitor in 2023
3.2 Global C1 Esterase Inhibitor Revenue by Manufacturers
3.2.1 Global C1 Esterase Inhibitor Revenue by Manufacturers (2019-2024)
3.2.2 Global C1 Esterase Inhibitor Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by C1 Esterase Inhibitor Revenue in 2023
3.3 Global Key Players of C1 Esterase Inhibitor, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global C1 Esterase Inhibitor Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global C1 Esterase Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of C1 Esterase Inhibitor, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of C1 Esterase Inhibitor, Product Offered and Application
3.8 Global Key Manufacturers of C1 Esterase Inhibitor, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global C1 Esterase Inhibitor Sales by Type
4.1.1 Global C1 Esterase Inhibitor Historical Sales by Type (2019-2024)
4.1.2 Global C1 Esterase Inhibitor Forecasted Sales by Type (2025-2030)
4.1.3 Global C1 Esterase Inhibitor Sales Market Share by Type (2019-2030)
4.2 Global C1 Esterase Inhibitor Revenue by Type
4.2.1 Global C1 Esterase Inhibitor Historical Revenue by Type (2019-2024)
4.2.2 Global C1 Esterase Inhibitor Forecasted Revenue by Type (2025-2030)
4.2.3 Global C1 Esterase Inhibitor Revenue Market Share by Type (2019-2030)
4.3 Global C1 Esterase Inhibitor Price by Type
4.3.1 Global C1 Esterase Inhibitor Price by Type (2019-2024)
4.3.2 Global C1 Esterase Inhibitor Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global C1 Esterase Inhibitor Sales by Application
5.1.1 Global C1 Esterase Inhibitor Historical Sales by Application (2019-2024)
5.1.2 Global C1 Esterase Inhibitor Forecasted Sales by Application (2025-2030)
5.1.3 Global C1 Esterase Inhibitor Sales Market Share by Application (2019-2030)
5.2 Global C1 Esterase Inhibitor Revenue by Application
5.2.1 Global C1 Esterase Inhibitor Historical Revenue by Application (2019-2024)
5.2.2 Global C1 Esterase Inhibitor Forecasted Revenue by Application (2025-2030)
5.2.3 Global C1 Esterase Inhibitor Revenue Market Share by Application (2019-2030)
5.3 Global C1 Esterase Inhibitor Price by Application
5.3.1 Global C1 Esterase Inhibitor Price by Application (2019-2024)
5.3.2 Global C1 Esterase Inhibitor Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada C1 Esterase Inhibitor Market Size by Type
6.1.1 US & Canada C1 Esterase Inhibitor Sales by Type (2019-2030)
6.1.2 US & Canada C1 Esterase Inhibitor Revenue by Type (2019-2030)
6.2 US & Canada C1 Esterase Inhibitor Market Size by Application
6.2.1 US & Canada C1 Esterase Inhibitor Sales by Application (2019-2030)
6.2.2 US & Canada C1 Esterase Inhibitor Revenue by Application (2019-2030)
6.3 US & Canada C1 Esterase Inhibitor Market Size by Country
6.3.1 US & Canada C1 Esterase Inhibitor Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada C1 Esterase Inhibitor Sales by Country (2019-2030)
6.3.3 US & Canada C1 Esterase Inhibitor Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe C1 Esterase Inhibitor Market Size by Type
7.1.1 Europe C1 Esterase Inhibitor Sales by Type (2019-2030)
7.1.2 Europe C1 Esterase Inhibitor Revenue by Type (2019-2030)
7.2 Europe C1 Esterase Inhibitor Market Size by Application
7.2.1 Europe C1 Esterase Inhibitor Sales by Application (2019-2030)
7.2.2 Europe C1 Esterase Inhibitor Revenue by Application (2019-2030)
7.3 Europe C1 Esterase Inhibitor Market Size by Country
7.3.1 Europe C1 Esterase Inhibitor Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe C1 Esterase Inhibitor Sales by Country (2019-2030)
7.3.3 Europe C1 Esterase Inhibitor Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China C1 Esterase Inhibitor Market Size
8.1.1 China C1 Esterase Inhibitor Sales (2019-2030)
8.1.2 China C1 Esterase Inhibitor Revenue (2019-2030)
8.2 China C1 Esterase Inhibitor Market Size by Application
8.2.1 China C1 Esterase Inhibitor Sales by Application (2019-2030)
8.2.2 China C1 Esterase Inhibitor Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia C1 Esterase Inhibitor Market Size by Type
9.1.1 Asia C1 Esterase Inhibitor Sales by Type (2019-2030)
9.1.2 Asia C1 Esterase Inhibitor Revenue by Type (2019-2030)
9.2 Asia C1 Esterase Inhibitor Market Size by Application
9.2.1 Asia C1 Esterase Inhibitor Sales by Application (2019-2030)
9.2.2 Asia C1 Esterase Inhibitor Revenue by Application (2019-2030)
9.3 Asia C1 Esterase Inhibitor Sales by Region
9.3.1 Asia C1 Esterase Inhibitor Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia C1 Esterase Inhibitor Revenue by Region (2019-2030)
9.3.3 Asia C1 Esterase Inhibitor Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America C1 Esterase Inhibitor Market Size by Type
10.1.1 Middle East, Africa and Latin America C1 Esterase Inhibitor Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America C1 Esterase Inhibitor Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America C1 Esterase Inhibitor Market Size by Application
10.2.1 Middle East, Africa and Latin America C1 Esterase Inhibitor Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America C1 Esterase Inhibitor Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America C1 Esterase Inhibitor Sales by Country
10.3.1 Middle East, Africa and Latin America C1 Esterase Inhibitor Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America C1 Esterase Inhibitor Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America C1 Esterase Inhibitor Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 CSL Behring
11.1.1 CSL Behring Company Information
11.1.2 CSL Behring Overview
11.1.3 CSL Behring C1 Esterase Inhibitor Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 CSL Behring C1 Esterase Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 CSL Behring Recent Developments
11.2 Takeda
11.2.1 Takeda Company Information
11.2.2 Takeda Overview
11.2.3 Takeda C1 Esterase Inhibitor Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Takeda C1 Esterase Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Takeda Recent Developments
11.3 Pharming Intellectual
11.3.1 Pharming Intellectual Company Information
11.3.2 Pharming Intellectual Overview
11.3.3 Pharming Intellectual C1 Esterase Inhibitor Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Pharming Intellectual C1 Esterase Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Pharming Intellectual Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 C1 Esterase Inhibitor Industry Chain Analysis
12.2 C1 Esterase Inhibitor Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 C1 Esterase Inhibitor Production Mode & Process
12.4 C1 Esterase Inhibitor Sales and Marketing
12.4.1 C1 Esterase Inhibitor Sales Channels
12.4.2 C1 Esterase Inhibitor Distributors
12.5 C1 Esterase Inhibitor Customers
13 Market Dynamics
13.1 C1 Esterase Inhibitor Industry Trends
13.2 C1 Esterase Inhibitor Market Drivers
13.3 C1 Esterase Inhibitor Market Challenges
13.4 C1 Esterase Inhibitor Market Restraints
14 Key Findings in The Global C1 Esterase Inhibitor Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global C1 Esterase Inhibitor Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Human
Table 3. Major Manufacturers of Recombinant
Table 4. Global C1 Esterase Inhibitor Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 5. Global C1 Esterase Inhibitor Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global C1 Esterase Inhibitor Revenue by Region (2019-2024) & (US$ Million)
Table 7. Global C1 Esterase Inhibitor Revenue by Region (2025-2030) & (US$ Million)
Table 8. Global C1 Esterase Inhibitor Revenue Market Share by Region (2019-2024)
Table 9. Global C1 Esterase Inhibitor Revenue Market Share by Region (2025-2030)
Table 10. Global C1 Esterase Inhibitor Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 11. Global C1 Esterase Inhibitor Sales by Region (2019-2024) & (K Unit)
Table 12. Global C1 Esterase Inhibitor Sales by Region (2025-2030) & (K Unit)
Table 13. Global C1 Esterase Inhibitor Sales Market Share by Region (2019-2024)
Table 14. Global C1 Esterase Inhibitor Sales Market Share by Region (2025-2030)
Table 15. Global C1 Esterase Inhibitor Sales by Manufacturers (2019-2024) & (K Unit)
Table 16. Global C1 Esterase Inhibitor Sales Share by Manufacturers (2019-2024)
Table 17. Global C1 Esterase Inhibitor Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 18. Global C1 Esterase Inhibitor Revenue Share by Manufacturers (2019-2024)
Table 19. Global Key Players of C1 Esterase Inhibitor, Industry Ranking, 2022 VS 2023 VS 2024
Table 20. C1 Esterase Inhibitor Price by Manufacturers 2019-2024 (USD/Unit)
Table 21. Global C1 Esterase Inhibitor Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global C1 Esterase Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in C1 Esterase Inhibitor as of 2023)
Table 23. Global Key Manufacturers of C1 Esterase Inhibitor, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of C1 Esterase Inhibitor, Product Offered and Application
Table 25. Global Key Manufacturers of C1 Esterase Inhibitor, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global C1 Esterase Inhibitor Sales by Type (2019-2024) & (K Unit)
Table 28. Global C1 Esterase Inhibitor Sales by Type (2025-2030) & (K Unit)
Table 29. Global C1 Esterase Inhibitor Sales Share by Type (2019-2024)
Table 30. Global C1 Esterase Inhibitor Sales Share by Type (2025-2030)
Table 31. Global C1 Esterase Inhibitor Revenue by Type (2019-2024) & (US$ Million)
Table 32. Global C1 Esterase Inhibitor Revenue by Type (2025-2030) & (US$ Million)
Table 33. Global C1 Esterase Inhibitor Revenue Share by Type (2019-2024)
Table 34. Global C1 Esterase Inhibitor Revenue Share by Type (2025-2030)
Table 35. C1 Esterase Inhibitor Price by Type (2019-2024) & (USD/Unit)
Table 36. Global C1 Esterase Inhibitor Price Forecast by Type (2025-2030) & (USD/Unit)
Table 37. Global C1 Esterase Inhibitor Sales by Application (2019-2024) & (K Unit)
Table 38. Global C1 Esterase Inhibitor Sales by Application (2025-2030) & (K Unit)
Table 39. Global C1 Esterase Inhibitor Sales Share by Application (2019-2024)
Table 40. Global C1 Esterase Inhibitor Sales Share by Application (2025-2030)
Table 41. Global C1 Esterase Inhibitor Revenue by Application (2019-2024) & (US$ Million)
Table 42. Global C1 Esterase Inhibitor Revenue by Application (2025-2030) & (US$ Million)
Table 43. Global C1 Esterase Inhibitor Revenue Share by Application (2019-2024)
Table 44. Global C1 Esterase Inhibitor Revenue Share by Application (2025-2030)
Table 45. C1 Esterase Inhibitor Price by Application (2019-2024) & (USD/Unit)
Table 46. Global C1 Esterase Inhibitor Price Forecast by Application (2025-2030) & (USD/Unit)
Table 47. US & Canada C1 Esterase Inhibitor Sales by Type (2019-2024) & (K Unit)
Table 48. US & Canada C1 Esterase Inhibitor Sales by Type (2025-2030) & (K Unit)
Table 49. US & Canada C1 Esterase Inhibitor Revenue by Type (2019-2024) & (US$ Million)
Table 50. US & Canada C1 Esterase Inhibitor Revenue by Type (2025-2030) & (US$ Million)
Table 51. US & Canada C1 Esterase Inhibitor Sales by Application (2019-2024) & (K Unit)
Table 52. US & Canada C1 Esterase Inhibitor Sales by Application (2025-2030) & (K Unit)
Table 53. US & Canada C1 Esterase Inhibitor Revenue by Application (2019-2024) & (US$ Million)
Table 54. US & Canada C1 Esterase Inhibitor Revenue by Application (2025-2030) & (US$ Million)
Table 55. US & Canada C1 Esterase Inhibitor Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 56. US & Canada C1 Esterase Inhibitor Revenue by Country (2019-2024) & (US$ Million)
Table 57. US & Canada C1 Esterase Inhibitor Revenue by Country (2025-2030) & (US$ Million)
Table 58. US & Canada C1 Esterase Inhibitor Sales by Country (2019-2024) & (K Unit)
Table 59. US & Canada C1 Esterase Inhibitor Sales by Country (2025-2030) & (K Unit)
Table 60. Europe C1 Esterase Inhibitor Sales by Type (2019-2024) & (K Unit)
Table 61. Europe C1 Esterase Inhibitor Sales by Type (2025-2030) & (K Unit)
Table 62. Europe C1 Esterase Inhibitor Revenue by Type (2019-2024) & (US$ Million)
Table 63. Europe C1 Esterase Inhibitor Revenue by Type (2025-2030) & (US$ Million)
Table 64. Europe C1 Esterase Inhibitor Sales by Application (2019-2024) & (K Unit)
Table 65. Europe C1 Esterase Inhibitor Sales by Application (2025-2030) & (K Unit)
Table 66. Europe C1 Esterase Inhibitor Revenue by Application (2019-2024) & (US$ Million)
Table 67. Europe C1 Esterase Inhibitor Revenue by Application (2025-2030) & (US$ Million)
Table 68. Europe C1 Esterase Inhibitor Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 69. Europe C1 Esterase Inhibitor Revenue by Country (2019-2024) & (US$ Million)
Table 70. Europe C1 Esterase Inhibitor Revenue by Country (2025-2030) & (US$ Million)
Table 71. Europe C1 Esterase Inhibitor Sales by Country (2019-2024) & (K Unit)
Table 72. Europe C1 Esterase Inhibitor Sales by Country (2025-2030) & (K Unit)
Table 73. China C1 Esterase Inhibitor Sales by Type (2019-2024) & (K Unit)
Table 74. China C1 Esterase Inhibitor Sales by Type (2025-2030) & (K Unit)
Table 75. China C1 Esterase Inhibitor Revenue by Type (2019-2024) & (US$ Million)
Table 76. China C1 Esterase Inhibitor Revenue by Type (2025-2030) & (US$ Million)
Table 77. China C1 Esterase Inhibitor Sales by Application (2019-2024) & (K Unit)
Table 78. China C1 Esterase Inhibitor Sales by Application (2025-2030) & (K Unit)
Table 79. China C1 Esterase Inhibitor Revenue by Application (2019-2024) & (US$ Million)
Table 80. China C1 Esterase Inhibitor Revenue by Application (2025-2030) & (US$ Million)
Table 81. Asia C1 Esterase Inhibitor Sales by Type (2019-2024) & (K Unit)
Table 82. Asia C1 Esterase Inhibitor Sales by Type (2025-2030) & (K Unit)
Table 83. Asia C1 Esterase Inhibitor Revenue by Type (2019-2024) & (US$ Million)
Table 84. Asia C1 Esterase Inhibitor Revenue by Type (2025-2030) & (US$ Million)
Table 85. Asia C1 Esterase Inhibitor Sales by Application (2019-2024) & (K Unit)
Table 86. Asia C1 Esterase Inhibitor Sales by Application (2025-2030) & (K Unit)
Table 87. Asia C1 Esterase Inhibitor Revenue by Application (2019-2024) & (US$ Million)
Table 88. Asia C1 Esterase Inhibitor Revenue by Application (2025-2030) & (US$ Million)
Table 89. Asia C1 Esterase Inhibitor Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 90. Asia C1 Esterase Inhibitor Revenue by Region (2019-2024) & (US$ Million)
Table 91. Asia C1 Esterase Inhibitor Revenue by Region (2025-2030) & (US$ Million)
Table 92. Asia C1 Esterase Inhibitor Sales by Region (2019-2024) & (K Unit)
Table 93. Asia C1 Esterase Inhibitor Sales by Region (2025-2030) & (K Unit)
Table 94. Middle East, Africa and Latin America C1 Esterase Inhibitor Sales by Type (2019-2024) & (K Unit)
Table 95. Middle East, Africa and Latin America C1 Esterase Inhibitor Sales by Type (2025-2030) & (K Unit)
Table 96. Middle East, Africa and Latin America C1 Esterase Inhibitor Revenue by Type (2019-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America C1 Esterase Inhibitor Revenue by Type (2025-2030) & (US$ Million)
Table 98. Middle East, Africa and Latin America C1 Esterase Inhibitor Sales by Application (2019-2024) & (K Unit)
Table 99. Middle East, Africa and Latin America C1 Esterase Inhibitor Sales by Application (2025-2030) & (K Unit)
Table 100. Middle East, Africa and Latin America C1 Esterase Inhibitor Revenue by Application (2019-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America C1 Esterase Inhibitor Revenue by Application (2025-2030) & (US$ Million)
Table 102. Middle East, Africa and Latin America C1 Esterase Inhibitor Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 103. Middle East, Africa and Latin America C1 Esterase Inhibitor Revenue by Country (2019-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America C1 Esterase Inhibitor Revenue by Country (2025-2030) & (US$ Million)
Table 105. Middle East, Africa and Latin America C1 Esterase Inhibitor Sales by Country (2019-2024) & (K Unit)
Table 106. Middle East, Africa and Latin America C1 Esterase Inhibitor Sales by Country (2025-2030) & (K Unit)
Table 107. CSL Behring Company Information
Table 108. CSL Behring Description and Major Businesses
Table 109. CSL Behring C1 Esterase Inhibitor Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 110. CSL Behring C1 Esterase Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. CSL Behring Recent Developments
Table 112. Takeda Company Information
Table 113. Takeda Description and Major Businesses
Table 114. Takeda C1 Esterase Inhibitor Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 115. Takeda C1 Esterase Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Takeda Recent Developments
Table 117. Pharming Intellectual Company Information
Table 118. Pharming Intellectual Description and Major Businesses
Table 119. Pharming Intellectual C1 Esterase Inhibitor Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 120. Pharming Intellectual C1 Esterase Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Pharming Intellectual Recent Developments
Table 122. Key Raw Materials Lists
Table 123. Raw Materials Key Suppliers Lists
Table 124. C1 Esterase Inhibitor Distributors List
Table 125. C1 Esterase Inhibitor Customers List
Table 126. C1 Esterase Inhibitor Market Trends
Table 127. C1 Esterase Inhibitor Market Drivers
Table 128. C1 Esterase Inhibitor Market Challenges
Table 129. C1 Esterase Inhibitor Market Restraints
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. C1 Esterase Inhibitor Product Picture
Figure 2. Global C1 Esterase Inhibitor Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global C1 Esterase Inhibitor Market Share by Type in 2023 & 2030
Figure 4. Human Product Picture
Figure 5. Recombinant Product Picture
Figure 6. Global C1 Esterase Inhibitor Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global C1 Esterase Inhibitor Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Pharmacy
Figure 10. C1 Esterase Inhibitor Report Years Considered
Figure 11. Global C1 Esterase Inhibitor Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global C1 Esterase Inhibitor Revenue 2019-2030 (US$ Million)
Figure 13. Global C1 Esterase Inhibitor Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 14. Global C1 Esterase Inhibitor Revenue Market Share by Region (2019-2030)
Figure 15. Global C1 Esterase Inhibitor Sales 2019-2030 ((K Unit)
Figure 16. Global C1 Esterase Inhibitor Sales Market Share by Region (2019-2030)
Figure 17. US & Canada C1 Esterase Inhibitor Sales YoY (2019-2030) & (K Unit)
Figure 18. US & Canada C1 Esterase Inhibitor Revenue YoY (2019-2030) & (US$ Million)
Figure 19. Europe C1 Esterase Inhibitor Sales YoY (2019-2030) & (K Unit)
Figure 20. Europe C1 Esterase Inhibitor Revenue YoY (2019-2030) & (US$ Million)
Figure 21. China C1 Esterase Inhibitor Sales YoY (2019-2030) & (K Unit)
Figure 22. China C1 Esterase Inhibitor Revenue YoY (2019-2030) & (US$ Million)
Figure 23. Asia (excluding China) C1 Esterase Inhibitor Sales YoY (2019-2030) & (K Unit)
Figure 24. Asia (excluding China) C1 Esterase Inhibitor Revenue YoY (2019-2030) & (US$ Million)
Figure 25. Middle East, Africa and Latin America C1 Esterase Inhibitor Sales YoY (2019-2030) & (K Unit)
Figure 26. Middle East, Africa and Latin America C1 Esterase Inhibitor Revenue YoY (2019-2030) & (US$ Million)
Figure 27. The C1 Esterase Inhibitor Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 28. The Top 5 and 10 Largest Manufacturers of C1 Esterase Inhibitor in the World: Market Share by C1 Esterase Inhibitor Revenue in 2023
Figure 29. Global C1 Esterase Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 30. Global C1 Esterase Inhibitor Sales Market Share by Type (2019-2030)
Figure 31. Global C1 Esterase Inhibitor Revenue Market Share by Type (2019-2030)
Figure 32. Global C1 Esterase Inhibitor Sales Market Share by Application (2019-2030)
Figure 33. Global C1 Esterase Inhibitor Revenue Market Share by Application (2019-2030)
Figure 34. US & Canada C1 Esterase Inhibitor Sales Market Share by Type (2019-2030)
Figure 35. US & Canada C1 Esterase Inhibitor Revenue Market Share by Type (2019-2030)
Figure 36. US & Canada C1 Esterase Inhibitor Sales Market Share by Application (2019-2030)
Figure 37. US & Canada C1 Esterase Inhibitor Revenue Market Share by Application (2019-2030)
Figure 38. US & Canada C1 Esterase Inhibitor Revenue Share by Country (2019-2030)
Figure 39. US & Canada C1 Esterase Inhibitor Sales Share by Country (2019-2030)
Figure 40. U.S. C1 Esterase Inhibitor Revenue (2019-2030) & (US$ Million)
Figure 41. Canada C1 Esterase Inhibitor Revenue (2019-2030) & (US$ Million)
Figure 42. Mexico C1 Esterase Inhibitor Revenue (2019-2030) & (US$ Million)
Figure 43. Europe C1 Esterase Inhibitor Sales Market Share by Type (2019-2030)
Figure 44. Europe C1 Esterase Inhibitor Revenue Market Share by Type (2019-2030)
Figure 45. Europe C1 Esterase Inhibitor Sales Market Share by Application (2019-2030)
Figure 46. Europe C1 Esterase Inhibitor Revenue Market Share by Application (2019-2030)
Figure 47. Europe C1 Esterase Inhibitor Revenue Share by Country (2019-2030)
Figure 48. Europe C1 Esterase Inhibitor Sales Share by Country (2019-2030)
Figure 49. Germany C1 Esterase Inhibitor Revenue (2019-2030) & (US$ Million)
Figure 50. France C1 Esterase Inhibitor Revenue (2019-2030) & (US$ Million)
Figure 51. UK C1 Esterase Inhibitor Revenue (2019-2030) & (US$ Million)
Figure 52. Italy C1 Esterase Inhibitor Revenue (2019-2030) & (US$ Million)
Figure 53. Russia C1 Esterase Inhibitor Revenue (2019-2030) & (US$ Million)
Figure 54. China C1 Esterase Inhibitor Sales Market Share by Type (2019-2030)
Figure 55. China C1 Esterase Inhibitor Revenue Market Share by Type (2019-2030)
Figure 56. China C1 Esterase Inhibitor Sales Market Share by Application (2019-2030)
Figure 57. China C1 Esterase Inhibitor Revenue Market Share by Application (2019-2030)
Figure 58. Asia C1 Esterase Inhibitor Sales Market Share by Type (2019-2030)
Figure 59. Asia C1 Esterase Inhibitor Revenue Market Share by Type (2019-2030)
Figure 60. Asia C1 Esterase Inhibitor Sales Market Share by Application (2019-2030)
Figure 61. Asia C1 Esterase Inhibitor Revenue Market Share by Application (2019-2030)
Figure 62. Asia C1 Esterase Inhibitor Revenue Share by Region (2019-2030)
Figure 63. Asia C1 Esterase Inhibitor Sales Share by Region (2019-2030)
Figure 64. Japan C1 Esterase Inhibitor Revenue (2019-2030) & (US$ Million)
Figure 65. South Korea C1 Esterase Inhibitor Revenue (2019-2030) & (US$ Million)
Figure 66. China Taiwan C1 Esterase Inhibitor Revenue (2019-2030) & (US$ Million)
Figure 67. Southeast Asia C1 Esterase Inhibitor Revenue (2019-2030) & (US$ Million)
Figure 68. India C1 Esterase Inhibitor Revenue (2019-2030) & (US$ Million)
Figure 69. Middle East, Africa and Latin America C1 Esterase Inhibitor Sales Market Share by Type (2019-2030)
Figure 70. Middle East, Africa and Latin America C1 Esterase Inhibitor Revenue Market Share by Type (2019-2030)
Figure 71. Middle East, Africa and Latin America C1 Esterase Inhibitor Sales Market Share by Application (2019-2030)
Figure 72. Middle East, Africa and Latin America C1 Esterase Inhibitor Revenue Market Share by Application (2019-2030)
Figure 73. Middle East, Africa and Latin America C1 Esterase Inhibitor Revenue Share by Country (2019-2030)
Figure 74. Middle East, Africa and Latin America C1 Esterase Inhibitor Sales Share by Country (2019-2030)
Figure 75. Brazil C1 Esterase Inhibitor Revenue (2019-2030) & (US$ Million)
Figure 76. Mexico C1 Esterase Inhibitor Revenue (2019-2030) & (US$ Million)
Figure 77. Turkey C1 Esterase Inhibitor Revenue (2019-2030) & (US$ Million)
Figure 78. Israel C1 Esterase Inhibitor Revenue (2019-2030) & (US$ Million)
Figure 79. GCC Countries C1 Esterase Inhibitor Revenue (2019-2030) & (US$ Million)
Figure 80. C1 Esterase Inhibitor Value Chain
Figure 81. C1 Esterase Inhibitor Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of C1 Esterase Inhibitor in 2030?
The global market size of C1 Esterase Inhibitor in 2030 was 194 Million USD.
What was the global market size of C1 Esterase Inhibitor in 2024?
Which region is expected to have the highest market share?
Which companies rank high in the global C1 Esterase Inhibitor market?
What is the annual compound growth rate of the global C1 Esterase Inhibitor market size from 2024 to 2030?
Related Reports
C1 Esterase Inhibitor- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for C1 Esterase Inhibitor was estimated to be worth US$ 151 million in 2025 and is projected to reach US$ 228 million, growing at a CAGR of 6.1% from 2026 to 2032.
Published Date: 2026-07-14
Pages: 123
USD 3950.00
(Single User License)
Global C1 Esterase Inhibitor Market Research Report 2026
The global C1 Esterase Inhibitor market was valued at US$ 151 million in 2025 and is anticipated to reach US$ 228 million by 2032, at a CAGR of 6.1% from 2026 to 2032.
Published Date: 2026-04-27
Pages: 104
USD 2900.00
(Single User License)
Global C1 Esterase Inhibitor Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global C1 Esterase Inhibitor market size was US$ 143 million in 2024 and is forecast to a readjusted size of US$ 216 million by 2031 with a CAGR of 6.1% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 71
USD 4250.00
(Single User License)
C1 Esterase Inhibitor- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for C1 Esterase Inhibitor was estimated to be worth US$ 143 million in 2024 and is forecast to a readjusted size of US$ 216 million by 2031 with a CAGR of 6.1% during the forecast period 2025-2031.
Published Date: 2025-02-25
Pages: 80
USD 3950.00
(Single User License)
Global C1 Esterase Inhibitor Market Research Report 2025
The global market for C1 Esterase Inhibitor was valued at US$ 143 million in the year 2024 and is projected to reach a revised size of US$ 216 million by 2031, growing at a CAGR of 6.1% during the forecast period.
Published Date: 2025-02-25
Pages: 71
USD 2900.00
(Single User License)
C1 Esterase Inhibitor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
C1 esterase inhibitor (C1-INH) is a protein found in the fluid part of your blood.
Published Date: 2024-01-24
Pages: 82
USD 3950.00
(Single User License)
Global C1 Esterase Inhibitor Market Research Report 2024
C1 esterase inhibitor (C1-INH) is a protein found in the fluid part of your blood.
Published Date: 2024-01-05
Pages: 72
USD 2900.00
(Single User License)
C1 Esterase Inhibitor- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for C1 Esterase Inhibitor was estimated to be worth US$ 151 million in 2025 and is projected to reach US$ 228 million, growing at a CAGR of 6.1% from 2026 to 2032.
Published: 2026-07-14
Pages: 123
USD 3950.00 (Single User License)Global C1 Esterase Inhibitor Market Research Report 2026
The global C1 Esterase Inhibitor market was valued at US$ 151 million in 2025 and is anticipated to reach US$ 228 million by 2032, at a CAGR of 6.1% from 2026 to 2032.
Published: 2026-04-27
Pages: 104
USD 2900.00 (Single User License)Global C1 Esterase Inhibitor Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global C1 Esterase Inhibitor market size was US$ 143 million in 2024 and is forecast to a readjusted size of US$ 216 million by 2031 with a CAGR of 6.1% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 71
USD 4250.00 (Single User License)C1 Esterase Inhibitor- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for C1 Esterase Inhibitor was estimated to be worth US$ 143 million in 2024 and is forecast to a readjusted size of US$ 216 million by 2031 with a CAGR of 6.1% during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 80
USD 3950.00 (Single User License)Global C1 Esterase Inhibitor Market Research Report 2025
The global market for C1 Esterase Inhibitor was valued at US$ 143 million in the year 2024 and is projected to reach a revised size of US$ 216 million by 2031, growing at a CAGR of 6.1% during the forecast period.
Published: 2025-02-25
Pages: 71
USD 2900.00 (Single User License)C1 Esterase Inhibitor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
C1 esterase inhibitor (C1-INH) is a protein found in the fluid part of your blood.
Published: 2024-01-24
Pages: 82
USD 3950.00 (Single User License)Global C1 Esterase Inhibitor Market Research Report 2024
C1 esterase inhibitor (C1-INH) is a protein found in the fluid part of your blood.
Published: 2024-01-05
Pages: 72
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now